Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
- PMID: 23636175
- DOI: 10.1038/ki.2013.135
Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
Abstract
Two types of alternatively activated macrophages, M(2a) induced by IL-4/IL-13 and M(2c) by IL-10/TGF-β, exhibit anti-inflammatory functions in vitro and protect against renal injury in vivo. Since their relative therapeutic efficacy is unclear, we compared the effects of these two macrophage subsets in murine adriamycin nephrosis. Both subsets significantly reduced renal inflammation and renal injury; however, M(2c) macrophages more effectively reduced glomerulosclerosis, tubular atrophy, interstitial expansion, and proteinuria than M(2a) macrophages. The M(2c) macrophages were also more effective than M(2a) in reduction of macrophage and CD4(+) T-cell infiltration in kidney. Moreover, nephrotic mice treated with M(2c) had a greater reduction in renal fibrosis than those treated with M(2a). M(2c) but not M(2a) macrophages induced regulatory T cells (Tregs) from CD4(+)CD25(-) T cells in vitro, and increased Treg numbers in local draining lymph nodes of nephrotic mice. To determine whether the greater protection with M(2c) was due to their capability to induce Tregs, the Tregs were depleted by PC61 antibody in nephrotic mice treated with M(2a) or M(2c). Treg depletion diminished the superior effects of M(2c) compared to M(2a) in protection against renal injury, inflammatory infiltrates, and renal fibrosis. Thus, M(2c) are more potent than M(2a) macrophages in protecting against renal injury due to their ability to induce Tregs.
Similar articles
-
IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis.J Am Soc Nephrol. 2010 Jun;21(6):933-42. doi: 10.1681/ASN.2009060592. Epub 2010 Mar 18. J Am Soc Nephrol. 2010. PMID: 20299353 Free PMC article.
-
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease.Kidney Int. 2007 Aug;72(3):290-9. doi: 10.1038/sj.ki.5002275. Epub 2007 Apr 18. Kidney Int. 2007. PMID: 17440493
-
CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.J Am Soc Nephrol. 2006 Oct;17(10):2731-41. doi: 10.1681/ASN.2005080842. Epub 2006 Sep 20. J Am Soc Nephrol. 2006. PMID: 16988067
-
Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.Kidney Int. 2011 Nov;80(9):915-925. doi: 10.1038/ki.2011.217. Epub 2011 Aug 3. Kidney Int. 2011. PMID: 21814171 Review.
-
Macrophage polarization in chronic kidney disease: a balancing act between renal recovery and decline?Am J Physiol Renal Physiol. 2019 Dec 1;317(6):F1409-F1413. doi: 10.1152/ajprenal.00380.2019. Epub 2019 Sep 30. Am J Physiol Renal Physiol. 2019. PMID: 31566432 Free PMC article. Review.
Cited by
-
The role of macrophage plasticity in neurodegenerative diseases.Biomark Res. 2024 Aug 13;12(1):81. doi: 10.1186/s40364-024-00624-7. Biomark Res. 2024. PMID: 39135084 Free PMC article. Review.
-
Releasable, Immune-Instructive, Bioinspired Multilayer Coating Resists Implant-Induced Fibrosis while Accelerating Tissue Repair.Adv Healthc Mater. 2024 Feb;13(5):e2302611. doi: 10.1002/adhm.202302611. Epub 2023 Dec 19. Adv Healthc Mater. 2024. PMID: 38095751 Free PMC article.
-
Drug delivery strategies to control macrophages for tissue repair and regeneration.Exp Biol Med (Maywood). 2016 May;241(10):1054-63. doi: 10.1177/1535370216649444. Epub 2016 May 6. Exp Biol Med (Maywood). 2016. PMID: 27190256 Free PMC article. Review.
-
Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy.Front Immunol. 2022 Jul 13;13:934299. doi: 10.3389/fimmu.2022.934299. eCollection 2022. Front Immunol. 2022. PMID: 35911736 Free PMC article.
-
Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects.Sci Rep. 2022 Jul 11;12(1):11728. doi: 10.1038/s41598-022-14846-y. Sci Rep. 2022. PMID: 35821386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials